MIRA INFORM REPORT

 

 

Report Date :

19.01.2011

 

IDENTIFICATION DETAILS

 

Correct Name :

SANOFI – AVENTIS VIETNAM COMPANY LIMITED 

 

 

Registered Office :

10 Ham Nghi - 1 District - Ho Chi Minh City - Vietnam

 

 

Country :

Vietnam

 

 

Financials (as on) :

31.12.2008

 

 

Date of Incorporation :

15.02.1994

 

 

Com. Reg. No.:

792A/GCNĐTDDC1-BKH

 

 

Legal Form :

Foreign Invested Company

 

 

Line of Business :

Trading and producing pharmaceutical products.

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2010

 

Country Name

Previous Rating

                   (01.04.2010)                  

Current Rating

(30.06.2010)

Vietnam

b1

b1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

SUBJECT IDENTIFICATION & LEGAL FORM

 

English Name

 

SANOFI – AVENTIS VIETNAM COMPANY LIMITED

Vietnamese Name

 

CONG TY TNHH SANOFI – AVENTIS VIETNAM

Trade name

 

SANOFI – AVENTIS VIETNAM CO., LTD

Type of Business

 

Foreign invested company

Year Established

 

1994

Business Registration No.

 

792A/GCNĐTDDC1-BKH

Date of Registration

 

15 Feb 1994

Place of Registration

 

Business Registration Office of Hochiminh City

Registered Investment Capital

 

8,754,256 USD

Chartered capital

 

4,368,234 USD

Tax code

 

0300782774

Total Employees

 

100

Size

 

Medium

 

 

 

company ADDRESSES

 

Head Office

Address

 

10 Ham Nghi - 1 District - Ho Chi Minh City - Vietnam

Telephone

 

(84-8) 38298526

Fax

 

(84-8) 39144801

 

Factory Address

Address

 

123 Nguyen Khoai, Ward 1 - 4 District - Ho Chi Minh City - Vietnam

Telephone

 

(84-8) 38255262 / 38255261 / 38255260 / 39400623

Fax

 

(84-8) 38254360

Website

 

www.sanofi-aventis.com.vn 

 

 

 

DIRECTORS

 

1 . NAME

 

Mr. MANZANO RÉGIS MANUEL

Position

 

CEO

ID Number/Passport

 

04FK14787

 

 

 

2 . NAME

 

Mr. NGUYEN PHUC DUC

Position

 

Human Resource Department

Nationality

 

Vietnamese

Email

 

PhucDuc.Nguyen@sanofi-aventis.com.vn

 

 

 

BUSINESS NATURE AND ACTIVITIES

 

Trading and producing pharmaceutical products.

 

 

 

IMPORT & EXPORT ACTIVITIES

 

IMPORT:

Types of products

 

Materials and pharmarceutical products

Market

 

France and Asean countries

 

EXPORT:

Types of products

 

The products

Market

 

Hong Kong, Cambodia, Laos

 

 

 

BANKERS

 

1. JOINT STOCK COMMERCIAL BANK FOR FOREIGN TRADE OF VIETNAM HO CHI MINH BRANCH

Address

 

No. 29 Ben Chuong Duong - 1 District - Ho Chi Minh City - Vietnam

Telephone

 

(84-8) 3829 7245 - 3823 0310 - 3823 0311

Fax

 

(84-8) 3829 7228

 

2. CITY BANK

Address

 

No.155 Nguyen Hue - 1 District - Ho Chi Minh City - Vietnam

Telephone

 

(84-8) 3824 2118 - 3825 7888

Fax

 

(84-8) 3824 2114

 

SHAREHOLDERS

 

NAME

 

SANOFI-AVENTIS GROUP

Address

 

174 Avenue De France, 75013 Paris -  France

Tel

 

+33 (0)1 53 77 40 00

Fax

 

+33 (0)1 53 77 41 33

Percentage

 

100%

 

 

 

FINANCIAL DATA

 

BALANCE SHEET

I: One VND

Balance sheet date

31/12/2008

31/12/2007

Number of weeks

52

52

ASSETS

A – CURRENT ASSETS

94,051,107,000

81,216,717,000

I. Cash and cash equivalents

4,403,890,000

4,590,158,000

1. Cash

4,403,890,000

4,590,158,000

2. Cash equivalents

0

0

II. Short-term investments

0

0

1. Short-term investments

0

0

2. Provisions for devaluation of short-term investments

0

0

III. Accounts receivable

22,904,878,000

34,207,907,000

1. Receivable from customers

21,992,998,000

26,915,944,000

2. Prepayments to suppliers

811,011,000

6,422,273,000

3. Inter-company receivable

0

0

4. Receivable according to the progress of construction

0

0

5. Other receivable

100,869,000

869,690,000

6. Provisions for bad debts

0

0

IV. Inventories

58,276,696,000

39,203,087,000

1. Inventories

58,776,496,000

39,457,048,000

2. Provisions for devaluation of inventories

-499,800,000

-253,961,000

V. Other Current Assets

8,465,643,000

3,215,565,000

1. Short-term prepaid expenses

1,797,419,000

1,035,804,000

2. VAT to be deducted

5,595,328,000

1,995,273,000

3. Taxes and other accounts receivable from the State

959,477,000

0

4. Other current assets

113,419,000

184,488,000

B. LONG-TERM ASSETS

91,626,237,000

70,983,262,000

I. Long term account receivable

0

0

1. Long term account receivable from customers

0

0

2. Working capital in affiliates

0

0

3. Long-term inter-company receivable

0

0

4. Other long-term receivable

0

0

5. Provisions for bad debts from customers

0

0

II. Fixed assets

90,953,540,000

70,029,117,000

1. Tangible assets

67,503,503,000

68,993,993,000

- Historical costs

179,280,308,000

166,730,664,000

- Accumulated depreciation

-111,776,805,000

-97,736,671,000

2. Financial leasehold assets

0

0

- Historical costs

0

0

- Accumulated depreciation

0

0

3. Intangible assets

540,568,000

994,247,000

- Initial costs

5,819,678,000

5,819,678,000

- Accumulated amortization

-5,279,110,000

-4,825,431,000

4. Construction-in-progress

22,909,469,000

40,877,000

III. Investment property

0

0

Historical costs

0

0

Accumulated depreciation

0

0

IV. Long-term investments

0

0

1. Investments in affiliates

0

0

2. Investments in business concerns and joint ventures

0

0

3. Other long-term investments

0

0

4. Provisions for devaluation of long-term investments

0

0

VI. Other long-term assets

672,697,000

954,145,000

1. Long-term prepaid expenses

0

418,978,000

2. Deferred income tax assets

672,697,000

535,167,000

3. Other long-term assets

0

0

TOTAL ASSETS

185,677,344,000

152,199,979,000

 

LIABILITIES

A- LIABILITIES

39,326,635,000

35,654,240,000

I. Current liabilities

38,467,678,000

35,129,752,000

1. Short-term debts and loans

0

0

2. Payable to suppliers

33,913,281,000

12,959,417,000

3. Advances from customers

0

0

4. Taxes and other obligations to the State Budget

565,072,000

2,333,833,000

5. Payable to employees

530,041,000

639,691,000

6. Accrued expenses

3,140,433,000

2,148,662,000

7. Inter-company payable

0

0

8. Payable according to the progress of construction contracts

0

0

9. Other payable

318,851,000

17,048,149,000

10. Provisions for short-term accounts payable

0

0

II. Long-Term Liabilities

858,957,000

524,488,000

1. Long-term accounts payable to suppliers

0

 

2. Long-term inter-company payable

0

0

3. Other long-term payable

0

0

4. Long-term debts and loans

0

0

5. Deferred income tax payable

0

0

6. Provisions for unemployment allowances

858,957,000

524,488,000

7. Provisions for long-term accounts payable

0

0

B- OWNER’S EQUITY

146,350,709,000

116,545,739,000

I. OWNER’S EQUITY

146,350,709,000

116,545,739,000

1. Capital

49,756,688,000

49,756,688,000

2. Share premiums

0

0

3. Other sources of capital

0

0

4. Treasury stocks

0

0

5. Differences on asset revaluation

0

0

6. Foreign exchange differences

0

0

7. Business promotion fund

0

0

8. Financial reserved fund

0

0

9. Other funds

0

0

10. Retained earnings

96,594,021,000

66,789,051,000

11. Construction investment fund

0

0

II. Other sources and funds

0

0

1. Bonus and welfare funds

0

0

2. Sources of expenditure

0

0

3. Fund to form fixed assets

0

0

MINORITY’S INTEREST

0

0

TOTAL LIABILITIES AND OWNER’S EQUITY

185,677,344,000

152,199,979,000

 

 

PROFIT & LOSS STATEMENT

Description

FY2008

FY2007

1. Total Sale

167,874,495,000

126,243,039,000

2. Deduction item

2,763,329,000

1,490,207,000

3. Net sale

165,111,166,000

124,752,832,000

4. Costs of goods sold

109,852,112,000

76,214,415,000

5. Gross profit

55,259,054,000

48,538,417,000

6. Financial income

118,278,000

1,025,901,000

7. Financial expenses

1,911,454,000

1,132,983,000

- In which: Loan interest expenses

716,702,000

241,819,000

8. Selling expenses

9,317,385,000

8,678,411,000

9. Administrative overheads

5,105,806,000

3,265,591,000

10. Net operating profit

39,042,687,000

36,487,333,000

11. Other income

1,429,000

0

12. Other expenses

0

40,488,000

13. Other profit /(loss)

1,429,000

-40,488,000

14. Total accounting profit before tax

39,044,116,000

36,446,845,000

15. Current corporate income tax

9,376,677,000

10,972,186,000

16. Deferred corporate income tax

137,531,000

0

17. Profit after tax

29,529,908,000

25,474,659,000

 

 

FINANCIAL RATIOS AND AVERAGE INDUSTRY RATIOS

Description

FY2008

FY2007

Average Industry

Current liquidity ratio

2.44

2.31

2.06

Quick liquidity ratio

0.93

1.20

1.33

Inventory circle

2.25

1.94

3.96

Average receive period

50.63

100.09

128.92

Utilizing asset performance

0.89

0.82

1.22

Liability by total asset

21.18

23.43

56.56

Liability by owner equity

26.87

30.59

344.11

Ebit / Total asset (ROA)

21.41

24.11

9.12

Ebit / Owner's equity (ROE)

27.17

31.48

15.93

Ebit / Total sale (NPM)

23.68

29.06

7.52

Gross profit / Total sale (GPM)

32.92

38.45

24.83

Note: The Average Industry was calculated by Vietnam Credit based on our owned statistical data

 

 

 

PAYMENT HISTORY & PERFORMANCE EXPERIENCES

 

Trade Morality

 

Fair

Liquidity

 

Medium

Payment status

 

Above Average

Financial Situation

 

Above Average

Development trend

 

Uptrend

Litigation data

 

No

Bankruptcy

 

No

Sale Methods

 

Retailer and Wholesaler

Public opinion

 

Good

 

 

CREDIT INQUIRY: 125,000 USD against DA in term.

The Subject can meet this credit inquiry.

 

 

 

INTERPRETATION ON THE SCORES

 

The subject is 100% foreign invested company, which was founded in 1994 and started operation in 1996. It is one of the leading companies specializing in trading and producing pharmaceutical products in Vietnam.

Formerly, the subject’s name was AVENTIS SRL COMPANY LIMITED and invested by AVENTIS GROUP. In 2004, AVENTIS GROUP merged with SANOFI-SYNTHELABO GROUP into SANOFI-AVENTIS GROUP. (In there, SANOFI-SYNTHELABO GROUP was found from the mergence between SANOFI GROUP and SYNTHELABO GROUP in May 1999). Since that time, the subject was changed name and operates as a factory of SANOFI-AVENTIS GROUP in Vietnam. SANOFI-AVENTIS GROUP has headquarters at Paris, France.

Currently, the presence of SANOFI-AVENTIS GROUP in Vietnam includes SANOFI-AVENTIS VIETNAM CO., LTD and SANOFI-SYNTHELABO VIETNAM PHARMACEUTICAL JVC. SANOFI AVENTIS was known with inventions which have many useful for people likes vaccine H5N1 and kinks of vaccine for children… SANOFI-AVENTIS with Corbiere Cacium product, Plavix, Lactacyd, Taxotere, Enterogermina, Amaryl, Acemuc ... and many other products used to receive information of many patients in Vietnam.

The company has diversified list of products produced domestically and imported, meet the needs of treatment and health care in different areas (cardiovascular, infectious diseases, cancer, internal medicine diseases ...).

The main imported market of the subject is France, Germany, Italy, Spain, Netherlands, Switzerland, and China and Asean countries. The subject’s pharmaceutical products are very popular in Vietnam market. Besides, its products also are exported to Hong Kong, Cambodia, Laos.

Operated for a long time and having many strong supports from the group so market share of the subject is large. The competitiveness of the subject is strong. The premises and facilities of the subject are fair standard. The subject’s production and operations well.

In 2008, economic was influenced by crisis. However, of the business activities of the subject is special – relative to health, medical so the needs of subject’s products is stable, subject’s production and operations operates well.

According to financial statement, financial situation of the subject in 2007, 2008 are fair, total sale and profits was high. We have no financial statement in 2009, but according to some information we collected, sale and profit of the subject are good. Liquidity ratios are acceptable. In general, the subject has capacity to meet normal financial commitments.

 

 

APPENDIXES

 

INDUSTRY DATA

 

Industry code

Growth speed (%)

Total employees 2009 (Thousand)

Total enterprises

Annual average capital of enterprises

Predict 2010

2009

Agriculture, Forestry and Fishing

2.8

3.0

24,788.5

2,399

50,530

Trade and Services

7.5

11

10,517.9

79,181

1,754,973

Construction

7

11.3

2,692.8

17,783

248,268

Manufacturing

12

7.6

7,591.2

30,786

967,068

 

ECONOMIC INDICATORS

 

 

2009 

2008 

2007 

Population (Million person)

87

86.1

85.1

Gross Domestic Products (US$ billion)

91

84.9

71.2

GDP Growth (%)

5.32

6.2

8.5

GDP Per Capita (US$)

1,080

1,040

814

Inflation (% Change in Composite CPI)

6.88

24.4

8.3

 

SERVICE TRADE PERFORMANCE

 

Billion USD 

2009 

2008 

2007 

Exports

56.6

62.9

48.6

Imports

68.8

76.6

58.9

Trade Balance

-12.2

-14.6

-10.3

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.53

UK Pound

1

Rs.72.56

Euro

1

Rs.60.62

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.